Drug Database
G04 UROLOGICALS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- G04BD Drugs for urinary frequency and incontinence
- G04BD02 flavoxate
- G04BD04 oxybutynin
- G04BD06 propiverine
- G04BD07 tolterodine
- G04BD08 solifenacin
- G04BD09 trospium
- G04BD10 darifenacin
- G04BD11 fesoterodine
- G04BD12 mirabegron
- G04BE01 alprostadil
- G04BE03 sildenafil
- G04BE08 tadalafil
- G04BE09 vardenafil
- G04BE10 avanafil
- G04BE11 udenafil
- G04BX14 dapoxetine
- G04BX15 pentosan polysulfate sodium
- G04CA01 alfuzosin
- G04CA02 tamsulosin
- G04CA03 terazosin
- G04CA52 tamsulosin and dutasteride
- G04CA53 tamsulosin and solifenacin
- G04CB01 finasteride
- G04CB02 dutasteride
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).